Inactive Instrument

Analyst Reco. Churchill Capital Corp Nyse

Equities

CCC.U

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Goldman Sachs Adjusts Price Target on Clarivate to $7.50 From $8.50, Maintains Buy Rating	May. 09	MT
Barclays Trims Price Target on Clarivate to $6 From $7, Maintains Underweight Rating	Feb. 28	MT
Oppenheimer Trims Clarivate Price Target to $10 From $11, Maintains Outperform Rating	Feb. 28	MT
RBC Cuts Price Target on Clarivate to $8 From $10, Cites Limited Visibility on Second-Half Turnaround; Sector Perform Kept	Feb. 28	MT
RBC Raises Price Target on Clarivate to $10 From $8, Expects Return to Growth in 2024, Keeps Sector Perform Rating	Jan. 22	MT
Oppenheimer Ups Price Target on Clarivate to $11 From $10, Keeps Outperform Rating	Jan. 08	MT
Wells Fargo Downgrades Clarivate to Underweight From Equalweight, Price Target is $8	Dec. 15	MT
Oppenheimer Adjusts Clarivate Price Target to $10 From $11, Maintains Outperform Rating	23-10-05	MT
Citigroup Cuts Price Target on Clarivate to $8 From $10, Maintains Neutral Rating	23-09-26	MT
Barclays Downgrades Clarivate to Underweight From Equal Weight, Adjusts Price Target to $7 From $8	23-09-08	MT
RBC Downgrades Clarivate to Sector Perform From Outperform, Says Potential for Strategic Optionality has Declined, Cuts Price Target to $8 From $9	23-08-25	MT
BofA Securities Downgrades Clarivate to Underperform From Neutral, Adjusts Price Target to $6 From $10	23-08-07	MT
Wells Fargo Downgrades Clarivate to Equalweight From Overweight, Adjusts Price Target to $8 From $15	23-08-04	MT
Oppenheimer Adjusts Clarivate Price Target to $11 From $12, Maintains Outperform Rating	23-08-04	MT
RBC Cuts Price Target on Clarivate to $9 From $14, Maintains Outperform Rating	23-08-04	MT
Oppenheimer Adjusts Clarivate Price Target to $12 From $11, Maintains Outperform Rating	23-07-05	MT
Oppenheimer Initiates Coverage on Clarivate With Outperform Rating, $11 Price Target	23-06-13	MT
Goldman Sachs Cuts Clarivate's Price Target to $11 From $12.40, Buy Rating Maintained	23-05-10	MT
Morgan Stanley Adjusts Price Target on Clarivate to $11 From $12, Maintains Equal-Weight Rating	23-05-10	MT
Wells Fargo Adjusts Price Target on Clarivate to $15 From $14, Maintains Overweight Rating	23-03-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Churchill Capital Corp Nyse

Equities

CCC.U

Analyst Reco.

Filters